Get the Stockscreener App
2.22
9.39%
-0.23
Medicus Pharma Ltd stock is traded at $2.22, with a volume of 590.01K.
It is down -9.39% in the last 24 hours and down -27.92% over the past month.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
See More
Previous Close:
$2.45
Open:
$2.22
24h Volume:
590.01K
Relative Volume:
1.36
Market Cap:
$35.63M
Revenue:
-
Net Income/Loss:
$-16.51M
P/E Ratio:
-1.2131
EPS:
-1.83
Net Cash Flow:
$-15.68M
1W Performance:
+13.27%
1M Performance:
-27.92%
6M Performance:
-44.50%
1Y Performance:
+0.00%
1-Day Range:
$2.19
$2.4384
1-Week Range:
$1.88
$2.48
52-Week Range:
$1.80
$8.94
Medicus Pharma Ltd Stock (MDCX) Company Profile
Name
Medicus Pharma Ltd
Sector
Industry
Phone
610-540-7515
Address
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
Compare MDCX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDCX
Medicus Pharma Ltd
|
2.22 | 35.63M | 0 | -16.51M | -15.68M | -1.83 |
|
LLY
Lilly Eli Co
|
711.68 | 625.77B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
179.29 | 424.47B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
210.60 | 364.92B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
126.98 | 240.07B | 53.40B | 13.68B | 16.89B | 6.9231 |
|
MRK
Merck Co Inc
|
87.37 | 210.36B | 63.43B | 16.42B | 14.72B | 6.49 |
Medicus Pharma Ltd Stock (MDCX) Latest News
Biotech at a Pivotal Moment: Four Stocks Defining The Transformation (MDCX, IOBT, INSM, RNA) - openPR.com
Medicus Pharma (NASDAQ:MDCX) Solution To Vaccine Cold Chain Storage Could Upend $40 Billion+ Market - MarketScreener
Biotech’s Big Comeback: 4 Stocks Poised to Ride the Resurgence (MDCX, ARVN, RYTM, ENTA) - FinancialContent
Medicus Pharma Ltd. Outperforms Peers on Volume MetricsBear Alert & Reliable Breakout Forecasts - beatles.ru
Biotech's Big Comeback: 4 Stocks Poised to Ride the Resurgence (MDCX, ARVN, RYTM, ENTA) - MarketScreener
Medicus Pharma Ltd. Sees Relief Buying After Extended DropPortfolio Value Report & Consistent Profit Focused Trading Strategies - metal.it
Bullish Candlestick Pattern Forms in Medicus Pharma Ltd.July 2025 Levels & Weekly Stock Performance Updates - newsyoung.net
Candlestick Reversal Detected on Medicus Pharma Ltd.’s ChartConsistent Profit Pattern Recognition Tools Shared - 선데이타임즈
Is Medicus Pharma Ltd. still a buy after recent gainsDaily Gain Targeted Stock List - thegnnews.com
Will Medicus Pharma Ltd. Equity Warrant Reverse From Oversold ConditionsEntry and Exit Strategy Optimizer Tool Tested - sundaytimes.kr
Trapped Investors in Medicus Pharma Ltd. Equity Warrant Await Breakout SignalStock Portfolio Allocation Guidance for Volatile Markets - 선데이타임즈
Medicus Pharma Ltd. SEC 10-Q Report - TradingView
Is Medicus Pharma Ltd. affected by consumer sentimentFree Breakout Stock Scanner - classian.co.kr
Published on: 2025-08-08 08:53:03 - beatles.ru
Medicus Pharma and HelixNano Partner to Develop Thermostable, Needle-Free mRNA Vaccines - AInvest
Medicus Pharma and HelixNano sign MOU to co-develop thermostable, needle-free mRNA vaccines - Proactive financial news
Medicus Pharma to acquire Antev - MSN
Transact Technologies Incorporated shares rise 1.75% intraday after Medicus Pharma Ltd. and Helix Nanotechnologies Inc. announced a non-binding memorandum of understanding. - AInvest
Medicus Pharma and HelixNano agree outline deal to develop heat-stable vaccines - Proactive financial news
Medicus Pharma announces MoU with HelixNano - The Pharma Letter
Medicus Pharma LtdCo And Helixnano Enter MoU For Vaccine DevelopmentSEC Filing - TradingView
Medicus Pharma and HelixNano Announce Vaccine Collaboration - TipRanks
Medicus Pharma Ltd. Announces a Memorandum of Understanding (MOU) with Helix Nanotechnologies Inc. to Develop Thermostable Infectious Disease Vaccines - Newsfile
The Biggest Takeaways From Boeing's Q2 Earnings Report - The Globe and Mail
Is it the right time to buy Medicus Pharma Ltd. stockTrack high-yield stocks before they peak - Jammu Links News
What is the dividend policy of Medicus Pharma Ltd. stockBuild a portfolio that grows with the market - Jammu Links News
What makes Medicus Pharma Ltd. Equity Warrant stock price move sharplyFree Market Volatility Navigation Tips - Jammu Links News
When is Medicus Pharma Ltd. stock expected to show significant growthTurbocharged investment results - Jammu Links News
What analysts say about Medicus Pharma Ltd. stockNavigate market volatility with smart strategies - Jammu Links News
What are the technical indicators suggesting about Medicus Pharma Ltd. Equity WarrantGet expert analysis on top stock picks - Jammu Links News
What catalysts could drive Medicus Pharma Ltd. stock higher in 2025Build a portfolio for long-term financial success - Jammu Links News
How many analysts rate Medicus Pharma Ltd. Equity Warrant as a “Buy”Capitalize on fast-growing investment opportunities - Jammu Links News
How strong is Medicus Pharma Ltd. company’s balance sheetDiscover high-impact stocks for growth - Jammu Links News
What are the latest earnings results for Medicus Pharma Ltd. Equity WarrantAchieve breakthrough gains with expert advice - Jammu Links News
Is Medicus Pharma Ltd. Equity Warrant stock overvalued or undervaluedRapid growth trajectories - Jammu Links News
When is Medicus Pharma Ltd. Equity Warrant stock expected to show significant growthPhenomenal investment performance - Jammu Links News
What are analysts’ price targets for Medicus Pharma Ltd. Equity Warrant in the next 12 monthsAchieve breakthrough gains with expert advice - Jammu Links News
Is Medicus Pharma Ltd. a growth stock or a value stockAccess high-quality stock research instantly - Jammu Links News
How does Medicus Pharma Ltd. Equity Warrant compare to its industry peersInvest smarter with advanced market data - Jammu Links News
Why is Medicus Pharma Ltd. Equity Warrant stock attracting strong analyst attentionFree Consultation - Jammu Links News
How volatile is Medicus Pharma Ltd. Equity Warrant stock compared to the marketConsistently exceptional gains - Jammu Links News
Why is Medicus Pharma Ltd. stock attracting strong analyst attentionInvest confidently with professional market insights - Jammu Links News
What is the risk reward ratio of investing in Medicus Pharma Ltd. Equity Warrant stockAchieve rapid portfolio growth with expert guidance - Jammu Links News
What are the technical indicators suggesting about Medicus Pharma Ltd.Stay ahead with daily expert stock picks - Jammu Links News
How many analysts rate Medicus Pharma Ltd. as a “Buy”Achieve rapid portfolio growth with expert guidance - Jammu Links News
Medicus Pharma Ltd. Crosses 200 Day MA — Signal or NoiseBuy Alerts With Low Risk Confirmation Noted - metal.it
What institutional investors are buying Medicus Pharma Ltd. stockRetirement Planning Target Finder Backed By Experts - Jammu Links News
Does Medicus Pharma Ltd. Equity Warrant stock perform well during market downturnsDaily Trading Review That Work - Jammu Links News
How Medicus Pharma Ltd. Equity Warrant stock performs during market volatilityBuy Alerts With Low Risk Confirmation Noted - beatles.ru
Medicus Pharma Ltd Stock (MDCX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Medicus Pharma Ltd Stock (MDCX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| VELOCITY FUND PARTNERS, LP | 10% Owner |
May 20 '25 |
Sale |
7.72 |
75,000 |
578,940 |
3,248,741 |
1.46%
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):